P89 Chlamydia Screening in Family Planning: Maximizing Screening Yield Using Existing Testing Resources

Tuesday, March 13, 2012
Hyatt Exhibit Hall
Sarah Goldenkranz, MPH, Cardea, Seattle, WA, Charlie Rabins, MPH, Health Care Education and Training, Carmel, IN and Elizabeth Torrone, MSPH, PhD, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA

Background: The Infertility Prevention Project (IPP) subsidizes chlamydia screening and treatment prioritizing all sexually-active women aged <26 years. However, resources are limited. Since prevalence is highest among adolescents, we hypothesized that targeted screening of adolescents could increase the number of infections detected.

Objectives: 1) Estimate the additional chlamydia cases that could potentially be detected by re-allocating existing testing resources to adolescents; 2) Identify opportunities to increase adolescent screening.

Methods: We determined chlamydia screening coverage, test volume, and positivity in family planning clinics by age, using programmatic data (Title X and IPP data, and Family Planning Annual Reports) in IPP Region X (northwest), Region V (midwest), and nationally.  We calculated the additional infections that could have been detected by re-allocating testing resources to cover 100% of female clients aged 10-19 years, with remaining tests allocated to clients aged 20-24 years; re-allocation model assumed equal chlamydia prevalence among females screened and not screened.  We assessed current screening coverage by visit characteristics in Region X.

Results: Adolescent screening coverage was 40% (Region X, 2010), 48% (Region V, 2010), and 33% (nationally, 2009). Re-allocating tests to screen all adolescents could have detected 1,257 more infections (28% increase) in Region X, 4,068 more (35% increase) in Region V, and 43,032 more (33% increase) nationally. Among adolescents, screening was more common at initial/annual visits compared to other visit types (OR=7.0 (6.7, 7.3)).

Conclusions: Theoretically, there are enough testing resources to cover 100% of adolescent females in IPP family planning clinics, and targeting adolescents could potentially detect 33% more infections. Additionally, ensuring that all non-initial/annual visits include chlamydia screening may increase adolescent screening coverage.

Implications for Programs, Policy, and Research: This exploratory analysis suggests chlamydia screening of adolescents should be prioritized when resources are limited. A pilot intervention targeting adolescents in family planning clinics is needed to determine actual screening yield.